- Current report filing (8-K)
October 20 2010 - 5:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported)
October 19,
2010
Adolor
Corporation
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-30039
|
|
31-1429198
|
(State or other jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer
|
of incorporation)
|
|
|
|
Identification No.)
|
700 Pennsylvania Drive, Exton, PA
|
|
19341
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(484) 595-1500
Not Applicable
(Former name or former address, if changed
since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On
October 19, 2010, Adolor Corporation (the Company) issued a press
release announcing the initiation of a Phase 2 proof-of-concept study of
ADL5945 in patients suffering from opioid-induced constipation (OIC).
A
copy of the press release is furnished hereto as Exhibit 99.1 and
incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d)
|
Exhibits
.
|
|
|
|
|
|
|
|
Exhibit No.
|
|
Description
of Document
|
|
99.1
|
|
Press
Release of the Company dated October 19, 2010
|
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
ADOLOR
CORPORATION
|
|
|
|
|
|
By
|
/s/
John M. Limongelli
|
|
Name:
|
John
M. Limongelli
|
|
Title:
|
Sr. Vice President,
General Counsel and Secretary
|
Dated: October 20, 2010
3
EXHIBIT INDEX
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press
release of the Company dated October 19, 2010.
|
4
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024